leisure time -WSS

leisure time

author：knowledge 2025-10-03 00:41:02 - browse：8291

Adam's take main illustration — Molly Ferguson/STAT

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible.

The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts. The drug’s benefit for patients placed it “at the top of the heap,” he added.

For other, equally important data from the same study that did not fit Moonlake’s home-run narrative, the company took a DIY approach. Curious about how sonelokimab performed against a treatment that’s already approved for HS? Pull out a calculator and do the math yourself. How badly did a higher dose of the drug underperform a lower dose? Take a guess.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Listen: Racing for gene therapy & a pioneering approval

WSS

South Korea throws huge K

Drastic changes should bring profitability, startup health insurers say

Baltimore teen accused of firing into crowd during block party mass shooting

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

FDA panel issues narrow recommendation for Covid vaccine booster doses

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

hotspot

leisure time

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Moonlake's readout produced a cash windfall. Risks remain

Naloxone nonprofit donates 200,000 doses after FDA approval

Walensky prepares to leave CDC — and Congress — behind

Maui's cultural, historic landmarks damaged in the devastating wildfires

How to save PrEP access — and even expand it

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Tori Bowie and the unacceptable rates of Black maternal death

Cancer drug shortages' outsize impact on ovarian cancer patients

hotspot

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Eye stem cell transplant could help restore vision in injured people

Naloxone nonprofit donates 200,000 doses after FDA approval

Trump cancels press conference intended to dispute Georgia election interference charges

Patient advocates sound warning on FDA proposal on salt intake

focus

focus

focus

leisure time